Metamizole Noridem (Metamizole Sodium Monohydrate)

Metamizole Sodium works by non‑selectively inhibiting cyclooxygenase enzymes, which reduces prostaglandin production, and by acting on central nervous system pathways that modulate pain perception. This dual action yields both analgesic and antipyretic effects.

The dosage of Metamizole Noridem is determined by the prescribing clinician based on the patient’s condition, age, weight, and response. Healthcare professionals calculate the appropriate amount and frequency according to clinical guidelines and individual needs.

Safety data for Metamizole Noridem in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To order Metamizole Noridem, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metamizole belongs to the pyrazolone class, offering strong analgesic and antipyretic effects similar to NSAIDs but with a distinct mechanism. Compared with opioids, it provides pain relief without typical opioid‑related respiratory depression, though it carries a risk of agranulocytosis not seen with many other analgesics.

Metamizole Noridem should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vials in the original packaging to maintain sterility and stability until use.

Metamizole Noridem is administered by a healthcare professional via intramuscular or intravenous injection. The route, volume, and rate of infusion are determined by the prescriber, taking into account the clinical situation and patient tolerance.

The most serious risks include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Prompt medical evaluation is essential if signs of infection, rash, or breathing difficulties develop.

Metamizole Noridem should be avoided in patients with known hypersensitivity to metamizole or other pyrazolones, those with a history of agranulocytosis, and individuals taking concurrent NSAIDs or anticoagulants without careful monitoring. Caution is also advised for patients with severe renal or hepatic impairment.